Additionally, the phosphorylated tau protein (pTAU) levels in the E2 group was significantly lower than that in the AD group (t(2) = 16.35, p = 0.002), indicating the potential suppressive effect of estrogen on tau phosphorylation. Here, MAPT is linked to Alzheimer disease.